153 related articles for article (PubMed ID: 690839)
1. USP dissolution IV: comparison of methods.
Carstensen JT; Lai TY; Prasad VK
J Pharm Sci; 1978 Sep; 67(9):1303-7. PubMed ID: 690839
[TBL] [Abstract][Full Text] [Related]
2. Variation on the USP-NF rotating-basket dissolution apparatus and a new device for dissolution rate studies of solid dosage forms.
Haringer G; Poulsen BJ; Havemeyer RN
J Pharm Sci; 1973 Jan; 62(1):130-2. PubMed ID: 4682913
[No Abstract] [Full Text] [Related]
3. Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation.
Salehi N; Al-Gousous J; Hens B; Amidon GL; Ziff RM; Amidon GE
Mol Pharm; 2024 May; 21(5):2406-2414. PubMed ID: 38639477
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the continuous fluid exchange system in the USP basket-stirrer dissolution test assembly. Part I: pH-dissolution rate behavior.
Huynh-Ngoc T; Sirois G
J Pharm Belg; 1976; 58(6):589-98. PubMed ID: 16109
[No Abstract] [Full Text] [Related]
5. Investigating the effect of solubility and density gradients on local hydrodynamics and drug dissolution in the USP 4 dissolution apparatus.
D'Arcy DM; Liu B; Corrigan OI
Int J Pharm; 2011 Oct; 419(1-2):175-85. PubMed ID: 21843609
[TBL] [Abstract][Full Text] [Related]
6. Effect of basket mesh size on the hydrodynamics of a partially filled (500 mL) USP rotating basket dissolution testing Apparatus 1.
Sirasitthichoke C; Patel S; Reuter KG; Hermans A; Bredael G; Armenante PM
Int J Pharm; 2024 Jun; 658():124209. PubMed ID: 38718973
[TBL] [Abstract][Full Text] [Related]
7. Hydrodynamic investigation of USP dissolution test apparatus II.
Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
[TBL] [Abstract][Full Text] [Related]
8. USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations.
Rohrs BR; Burch-Clark DL; Witt MJ; Stelzer DJ
J Pharm Sci; 1995 Aug; 84(8):922-6. PubMed ID: 7500274
[TBL] [Abstract][Full Text] [Related]
9. Systematic error associated with apparatus 2 of the USP dissolution test III: limitations of calibrators and the USP suitability test.
Cox DC; Furman WB; Thornton LK; Moore TW; Jefferson EH
J Pharm Sci; 1983 Aug; 72(8):910-3. PubMed ID: 6620145
[TBL] [Abstract][Full Text] [Related]
10. Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus.
Cox DC; Furman WB
J Pharm Sci; 1982 Apr; 71(4):451-2. PubMed ID: 7086657
[No Abstract] [Full Text] [Related]
11. Time and temperature dependence of disintegration and correlation between dissolution and disintegration rate constants.
Carstensen JT; Kothari R; Prasad VK; Sheridan J
J Pharm Sci; 1980 Mar; 69(3):290-4. PubMed ID: 7381704
[TBL] [Abstract][Full Text] [Related]
12. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium.
Cox DC; Furman WB; Page DP
J Pharm Sci; 1983 Sep; 72(9):1061-4. PubMed ID: 6631694
[TBL] [Abstract][Full Text] [Related]
13. Dissolution testing of acetylsalicylic acid by a channel flow method-correlation to USP basket and intrinsic dissolution methods.
Peltonen L; Liljeroth P; Heikkilä T; Kontturi K; Hirvonen J
Eur J Pharm Sci; 2003 Aug; 19(5):395-401. PubMed ID: 12907290
[TBL] [Abstract][Full Text] [Related]
14. USP dissolution test I: adequacy of mixing.
Carstensen JT; Lai T; Prasad VK
J Pharm Sci; 1977 Apr; 66(4):607-8. PubMed ID: 853377
[No Abstract] [Full Text] [Related]
15. Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere.
Cox DC; Wells CE; Furman WB; Savage TS; King AC
J Pharm Sci; 1982 Apr; 71(4):395-9. PubMed ID: 7086644
[TBL] [Abstract][Full Text] [Related]
16. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
Cox DC; Furman WB
J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
[TBL] [Abstract][Full Text] [Related]
17. Comparison of operational characteristics of different dissolution testing systems.
Hardwidge EA; Sarapu AC; Laughlin WC
J Pharm Sci; 1978 Dec; 67(12):1732-5. PubMed ID: 722490
[TBL] [Abstract][Full Text] [Related]
18. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
Qureshi SA; McGilveray IJ
Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
[TBL] [Abstract][Full Text] [Related]
19. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
Baxter JL; Kukura J; Muzzio FJ
Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
[TBL] [Abstract][Full Text] [Related]
20. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
